Redução de dor, edema e trismo: benefícios do uso da dexametasona via intramuscular como medicação preemptiva na cirurgia oral / Reduction of pain, swelling and trismus: benefits of using intramuscular dexamethasone as preemptive medication in oral surgery / Reducción del dolor, edema y trismo: beneficios del uso de dexametasona intramuscular como medicación preventiva en cirugía oral

Complicações pós-operatórias como edema, dor e trismo são comuns em cirurgias orais. Terapias, como o uso de analgésicos e anti-inflamatórios, são indicadas para estas complicações. No entanto, intervenções pré-operatórias podem ser alternativas. Desta forma, o presente estudo avaliou o efeito da dexametasona no edema, intensidade de dor e abertura de boca (trismo) no pós-operatório de retirada de terceiros molares inferiores. Pacientes (n=14, 9 mulheres) foram incluídos em um estudo clínico, cruzado, cego, randomizado, placebo-controlado e boca dividida. Pacientes receberam aleatoriamente medicação preemptiva (dexametasona 8mg, intramuscular, músculo masseter) ou placebo (soro fisiológico) uma hora antes da primeira cirurgia. O procedimento contralateral foi realizado 21 dias após. Avaliou se o edema e a abertura bucal nos momentos pré-operatórios e no 3º e 7º dias pós-operatórios, além de dor espontânea (imediatamente, 2 e 24 horas, 3 dias e 7 dias). Os dados foram analisados usando anova de medidas repetidas seguida do teste post hoc LSD de Fisher. Comparado ao placebo, a medicação reduziu edema (3 dias), dor (2 e 24 horas) e trismo (3 dias). Os resultados sugerem que o uso preemptivo da dexametasona intramuscular é capaz de aumentar o bem-estar dos pacientes submetidos a cirurgias orais, tendo o potencial de reduzir os custos pós-operatórios... (AU)

Postoperative complications such as edema, pain, and trismus are common in oral surgery. Therapies, such as the use of painkillers and anti inflammatory drugs, are indicated for the reversal of these complications. However, preoperative (preemptive) interventions can be alternatives. Thus, the present study aimed to evaluate the effect of dexamethasone on edema, pain intensity, and mouth opening (trismus) in the postoperative period of removal of impacted lower third molars. Patients (n = 14, 9 women) were included in a clinical, crossover, blinded, randomized, placebo-controlled, and divided mouth study. Preemptive mediation (dexamethasone 8mg, intramuscular, masseter muscle) or placebo (saline) was randomly given before the first surgery. The contralateral procedure was performed 21 days later. In the postoperative period, edema, mouth opening (preoperative, 3 and 7 days), and spontaneous pain (immediately, 2 and 24 hours, 3 days and 7 days) were analyzed. The data were analyzed using the one-way repeated measures ANOVA followed by Fisher's LSD post hoc. Compared to placebo, the medication reduced edema (3 days), pain (2 and 24 hours), and trismus (3 days). The results suggest that the preemptive use of dexamethasone is able to increase the well-being of patients undergoing oral surgeries, with the potential to reduce postoperative costs... (AU)

Las complicaciones posoperatorias como hinchazón, dolor y trismo son comunes en las cirugías orales. Las terapias, como el uso de analgésicos y antiinflamatorios, están indicadas para estas complicaciones. Sin embargo, las intervenciones preoperatorias pueden ser alternativas. Así, el presente estudio evaluó el efecto de la dexametasona sobre el edema, la intensidad del dolor y la apertura de la boca (trismo) en el postoperatorio de remoción del tercer molar inferior. Los pacientes (n = 14, 9 mujeres) se incluyeron en un estudio clínico, cruzado, ciego, aleatorizado, controlado con placebo y de boca dividida. Los pacientes recibieron aleatoriamente medicación preventiva (8 mg de dexametasona, intramuscular, músculo masetero) o placebo (solución salina) una hora antes de la primera cirugía. El procedimiento contralateral se realizó 21 días después. Se evaluó el edema y la apertura de la boca en el preoperatorio y en el tercer y séptimo días postoperatorios, además del dolor espontáneo (inmediato, 2 y 24 horas, 3 días y 7 días). Los datos se analizaron utilizando anova de medidas repetidas seguido de la prueba post hoc de LSD de Fisher. En comparación con el placebo, el medicamento redujo el edema (3 días), el dolor (2 y 24 horas) y el trismo (3 días). Los resultados sugieren que el uso preventivo de dexametasona intramuscular puede aumentar el bienestar de los pacientes sometidos a cirugía oral, con el potencial de reducir los costos posoperatorios... (AU)

Occurrence of dermoid cyst in the floor of the mouth: the importance of differential diagnosis in pediatric patients

Abstract Lesions in the floor of the mouth can be a challenging diagnosis due to the variety of pathological conditions that might be found in this area. Within a broad range of lesions, attention has to be addressed to those that require specific management, such as a dermoid cyst (DC) and a ranula. Especially in pediatric patients, in whom the failure of diagnosis can postpone the correct treatment and cause sequelae later in life. DC, a developmental anomaly, is managed primarily by surgical resection. On the other hand, ranula is a pseudocyst that may be treated by marsupialization. This article reports a large and painful lesion in the floor of the mouth in a pediatric patient. With a diagnostic hypothesis of ranula, two surgical interventions were performed, but there were recurrences of the lesion. Subsequently, the patient was referred to the Oral and Maxillofacial Surgery Unit for re-evaluation. Computed tomography showed a semi-transparent image suggesting a cystic formation. Another surgical procedure was performed where the lesion was completely removed. Anatomopathological analysis confirmed the diagnosis of DC. The five-year follow-up showed no signs of recurrence. This article indicates that although DC in the floor of the mouth is rare, it should be considered in the differential diagnosis of other diseases in this area. This precaution may be particularly important in the following circumstances: 1) Similar lesions that have different therapeutic approaches and, 2) To prevent future sequelae in pediatric patients.

Evaluation of different procedure involved in the Transcranial Direct Current Stimulation (tDCS) technique experimental application

Introduction: The transcranial direct current stimulation (tDCS) is a non-invasive technique, which induces neuroplastic changes in the central nervous system of animals and humans. Furthermore, tDCS has been suggested as a therapeutic tool for pain management. The aim of this study was to standardize a non-invasive tDCS technique indexed by the nociceptive response of rats submitted to different conditions necessary to the tDCS application. Method: 60-day-old male Wistar rats (n=65), divided into 6 groups: control(C); non-active sham (NAS); active-sham (AS); active-sham restrained (ASR); non-active sham restrained (NASR); active tDCS treatment. Animals received treatment during 30 seconds (sham-active) or 20 minutes (restraint and tDCS)/8 days. Nociceptive threshold was assessed by Hot Plate test at baseline, immediately and 24h after the first session, immediately and 24h after the last session. Variance analysis of repeated measurements followed by Bonferroni was performed for intra-group comparison. Results: Physical restraint and 30 seconds stimulation (sham-tDCS) increased pain sensitivity (P≤0.05), and tDCS treatment was able to prevent the thermal hyperalgesia. Our original tDCS montage is similar to that used in the procedure with humans, because it is not an invasive technique. The electrodes are positioned on the head, and the animals are immobilized during the 20-minute treatment. As this procedure could involve behavior and neurochemical alterations due to stress induced by restriction (thus, it creates a research bias), we hypothesized that a 30-second electrical stimulus application (sham-tDCS) and the physical restriction used during tDCS treatment might alter nociceptive response in rats. Conclusion: There are methodological limitations in the present tDCS-technique. Although active-tDCS treatment is able to prevent these harmful effects, interference of these factors has to be considered during the results' analysis. Future adaptations of the tDCS-technique in rats are required to evaluate its therapeutic effects (AU)

Abordagens técnicas inovadoras em Cirurgia e Traumatologia Bucomaxilofacial / Innovative technique approaches in Oral and Maxillofacial Surgery

Ao longo da história, a ciência tem colaborado com o desenvolvimento de terapias que suprem as novas demandas da sociedade, sempre com o objetivo de manter a saúde e a integridade do ser humano. Avanços tecnológicos em áreas afins, como a anestesia geral e a introdução dos biomateriais, impulsionaram a evolução da Odontologia. Particularmente a Cirurgia e Traumatologia Bucomaxilofaciais (CTBMF) tem desenvolvido técnicas cirúrgicas mais elaboradas que geram benefícios a uma parcela da população que não possuía alternativas terapêuticas anteriormente. Equipes cirúrgicas brasileiras têm assumido papel de destaque na busca de suprir limitações terapêuticas. Como por exemplo, retenções dentárias sem possibilidades de tratamentos conservadores, hoje podem ser tratadas através de técnicas como a Apicotomia e a Laçada Dupla. Similarmente, pacientes portadores de anquilose da articulação temporomandibular (ATM) possuem opção de serem tratados com a Artroplastia Biconvexa de Puricelli. Esta técnica requer menor exérese tecidual, utiliza material aloplástico de baixo custo e restaura a função articular. E por fim, técnicas desenvolvidas no Brasil têm colaborado ao aperfeiçoamento de metodologias mundialmente consagradas, como é o caso da Osteotomia Mandibular de Puricelli que confere maior estabilidade entre os fragmentos ósseos nas cirurgias para correção de deformidades dentofaciais. Desta forma, o presente trabalho tem por objetivo a exposição e discussão da colaboração científica e técnica destas terapias cirúrgicas (desenvolvidas no Departamento de Cirurgia e Ortopedia da Universidade Federal do Rio Grande do Sul) nos diferentes procedimentos, onde são indicadas.

Throughout history, the development of science has collaborated with the progress of new therapies based on society's demands to maintain public health and its physical integrity. Technological development in basic areas (i.e. general anesthesia and biomaterials) helped the progress of Dental Science. For example, the Oral and Maxillofacial Surgery (OMS) was able to develop novel and more advanced surgical techniques bringing clinical benefits that did not exist earlier. Brazilian research groups have played an important role in the development of new alternatives to surpass these therapeutic limitations. For instance, some cases of tooth impaction, which could only be treated by dental extraction, are currently resolved through alternative surgical techniques such as Apicotomy and Double Traction, preventing tooth loss. Likewise, patients with temporomandibular joint (TMJ) ankylosis can be favored by a surgical treatment called Puricelli Biconvex Arthroplasty. This procedure has minimally invasive osteotomy, uses a financial affordable alloplastic material, and maintains joint stability. Finally, Brazilian techniques have contributed to improve other well-established surgical treatments. This is the case of the Puricelli Osteotomy, which provides a more stable position for the mandible during orthognathic surgery. Therefore, the aim of the present paper is to summarize and discuss the scientific and methodological contributions of these surgical techniques (developed by the Department of Surgery and Orthopedic of Universidade Federal do Rio Grande do Sul) and their indications.